PK11195 is a ligand of TSPO and is used in research targeting leishmaniasis, showing anti-parasitic activity against *Leishmania amazonensis*, *L. major*, and *L. braziliensis* with IC50 values of 14.2 μM, 8.2 μM, and 3.5 μM, respectively; it reduces the percentage of infected macrophages, the number of parasites per infected macrophage, and the number of viable intracellular parasites in a time- and dose-dependent manner; it also induces morphological alterations suggestive of autophagy and reduces MCP-1 and superoxide levels in *L. amazonensis*-infected macrophages.